Molecular Epidemiology in 591 Italian Probands With Nonsyndromic Retinitis Pigmentosa and Usher Syndrome.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 02 2021
Historique:
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 21 7 2021
Statut: ppublish

Résumé

To describe the molecular epidemiology of nonsyndromic retinitis pigmentosa (RP) and Usher syndrome (US) in Italian patients. A total of 591 probands (315 with family history and 276 sporadics) were analyzed. For 155 of them, we performed a family segregation study, considering a total of 382 relatives. Probands were analyzed by a customized multigene panel approach. Sanger sequencing was used to validate all genetic variants and to perform family segregation studies. Copy number variants of selected genes were analyzed by multiplex ligation-dependent probe amplification. Four patients who tested negative to targeted next-generation sequencing analysis underwent clinical exome sequencing. The mean diagnostic yield of molecular testing among patients with a family history of retinal disorders was 55.2% while the diagnostic yield including sporadic cases was 37.4%. We found 468 potentially pathogenic variants, 147 of which were unpublished, in 308 probands and 66 relatives. Mean ages of onset of the different classes of RP were autosomal dominant RP, 19.3 ± 12.6 years; autosomal recessive RP, 23.2 ± 16.6 years; X-linked RP, 13.9 ± 9.9 years; and Usher syndrome, 18.9 ± 9.5 years. We reported potential new genotype-phenotype correlations in three probands, two revealed by TruSight One testing. All three probands showed isolated RP caused by biallelic variants in genes usually associated with syndromes such as PERCHING and Senior-Loken or with retinal dystrophy, iris coloboma, and comedogenic acne syndrome. This is the largest molecular study of Italian patients with RP in the literature, thus reflecting the epidemiology of the disease in Italy with reasonable accuracy.

Identifiants

pubmed: 33576794
pii: 2772273
doi: 10.1167/iovs.62.2.13
pmc: PMC7884295
doi:

Substances chimiques

Extracellular Matrix Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13

Références

Ophthalmic Epidemiol. 2013;20(1):13-25
pubmed: 23350551
Genes (Basel). 2017 Oct 20;8(10):
pubmed: 29053603
Clin Genet. 1995 Sep;48(3):120-2
pubmed: 8556816
Science. 1998 Jun 12;280(5370):1753-7
pubmed: 9624053
Sci Rep. 2016 Sep 14;6:33248
pubmed: 27624628
Adv Exp Med Biol. 2018;1085:69-77
pubmed: 30578488
Invest Ophthalmol Vis Sci. 2011 Nov 25;52(12):9053-60
pubmed: 22025579
Orphanet J Rare Dis. 2012 Jan 25;7:8
pubmed: 22277662
Genome Med. 2010 May 27;2(5):34
pubmed: 20519033
Orphanet J Rare Dis. 2015 Jun 24;10:85
pubmed: 26103963
Int J Mol Sci. 2019 Nov 14;20(22):
pubmed: 31739639
Hum Mutat. 2012 Jun;33(6):963-72
pubmed: 22334370
Am J Kidney Dis. 2000 Dec;36(6):1271-5
pubmed: 11096053
Prog Retin Eye Res. 2010 Sep;29(5):335-75
pubmed: 20362068
Eur J Ophthalmol. 2019 Sep 30;:1120672119879392
pubmed: 31566003
Sci Rep. 2015 Dec 15;5:18287
pubmed: 26667666
BMJ Open Ophthalmol. 2019 Feb 16;4(1):e000234
pubmed: 30997404
Sci Rep. 2019 Jul 24;9(1):10712
pubmed: 31341231
Prog Retin Eye Res. 2018 Jan;62:1-23
pubmed: 29042326
Dev Ophthalmol. 2017;58:191-201
pubmed: 28351048
Exp Eye Res. 2014 May;122:9-12
pubmed: 24607488
Hum Genet. 2015 Feb;134(2):217-30
pubmed: 25472526
Ophthalmologe. 1994 Jun;91(3):322-8
pubmed: 8086748
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6753-6765
pubmed: 31378919
Ophthalmology. 2017 Sep;124(9):1314-1331
pubmed: 28559085
Int J Mol Sci. 2019 May 23;20(10):
pubmed: 31126147
Am J Ophthalmol. 2019 Apr;200:76-84
pubmed: 30582903
Orphanet J Rare Dis. 2006 Oct 11;1:40
pubmed: 17032466
Biomed Res Int. 2016;2016:6341870
pubmed: 28127548
PLoS One. 2016 Jan 14;11(1):e0145951
pubmed: 26766544
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Clin Genet. 2016 Aug;90(2):118-26
pubmed: 26853529
J Med Genet. 2012 May;49(5):322-6
pubmed: 22581970
BMC Ophthalmol. 2018 Jun 26;18(1):153
pubmed: 29940899
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034
Am J Hum Genet. 2016 Jul 7;99(1):236-45
pubmed: 27392078
Ophthalmology. 2019 Aug;126(8):1181-1188
pubmed: 30902645
Ophthalmic Paediatr Genet. 1992 Dec;13(4):227-36
pubmed: 1488223
Int Heart J. 2017 Feb 7;58(1):81-87
pubmed: 28003625

Auteurs

Leonardo Colombo (L)

Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy.

Paolo E Maltese (PE)

MAGI's Lab s.r.l., Rovereto, Italy.

Marco Castori (M)

Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

Said El Shamieh (S)

Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Christina Zeitz (C)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
CHNO des Quinze-Vingts, DHUSight Restore, INSERM-DGOS CIC1423, Paris, France.

Isabelle Audo (I)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
CHNO des Quinze-Vingts, DHUSight Restore, INSERM-DGOS CIC1423, Paris, France.

Alessandra Zulian (A)

MAGI's Lab s.r.l., Rovereto, Italy.

Carla Marinelli (C)

MAGI's Lab s.r.l., Rovereto, Italy.

Sabrina Benedetti (S)

MAGI's Lab s.r.l., Rovereto, Italy.

Alisia Costantini (A)

MAGI's Lab s.r.l., Rovereto, Italy.

Simone Bressan (S)

MAGI's Lab s.r.l., Rovereto, Italy.

Marcella Percio (M)

MAGI's Lab s.r.l., Rovereto, Italy.

Paolo Ferri (P)

Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy.

Andi Abeshi (A)

MAGI's Lab s.r.l., Rovereto, Italy.
Department of Otolaryngology, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Matteo Bertelli (M)

MAGI's Lab s.r.l., Rovereto, Italy.

Luca Rossetti (L)

Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH